Ad is loading...
RAEBX
Price
$43.24
Change
-$0.87 (-1.97%)
Updated
Nov 15 closing price
RGAHX
Price
$78.97
Change
-$1.33 (-1.66%)
Updated
Nov 15 closing price
Ad is loading...

RAEBX vs RGAHX

Header iconRAEBX vs RGAHX Comparison
Open Charts RAEBX vs RGAHXBanner chart's image
American Funds AMCAP R2E
Price$43.24
Change-$0.87 (-1.97%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$78.97
Change-$1.33 (-1.66%)
VolumeN/A
CapitalizationN/A
RAEBX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RAEBX vs. RGAHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAEBX is a Sell and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 298B vs. RAEBX (89.3B). RGAHX pays higher dividends than RAEBX: RGAHX (0.64) vs RAEBX (0.00). RAEBX was incepted earlier than RGAHX: RAEBX (10 years) vs RGAHX (9 years). RAEBX (31.00) and RGAHX (31.00) have comparable annual turnover. RAEBX (250) and RGAHX (250) have matching initial minimum investment requirements. RGAHX annual gain was more profitable for investors over the last year : 28.11 vs. RAEBX (22.74). RGAHX return over 5 years is better than : 53.44 vs. RAEBX (31.59).
RAEBXRGAHXRAEBX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years9 years-
Gain YTD16.77026.65663%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets89.3B298B30%
Annual Yield % from dividends0.000.640%
Returns for 1 year22.7428.1181%
Returns for 3 years-7.84-4.25184%
Returns for 5 years31.5953.4459%
Returns for 10 years45.05N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRXP1.190.03
+2.59%
NRX Pharmaceuticals
WSO520.74-5.05
-0.96%
Watsco
NPWR12.67-0.43
-3.28%
NET Power
QDEL36.18-2.78
-7.14%
QuidelOrtho Corp
FULC3.01-0.32
-9.49%
Fulcrum Therapeutics